10% Free customization
The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032, witnessing a CAGR of 9.80% during the forecast period 2023-2032. The growing use of biopharmaceutical products and improvements in viral testing technologies are expected to drive the growth of the biomanufacturing viral detection and quantification market in the European market. This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Market Introduction
The market for viral detection and quantification biomanufacturing in Europe is expanding quickly as a result of the growing use of biopharmaceutical products. Ensuring the safety, efficacy, and consistency of these products becomes increasingly important as the demand for biologics develops. Sturdy quality control procedures are necessary to comply with regulations and preserve product integrity. One such procedure is the measurement of viral contamination during biomanufacturing. As a result, the European biomanufacturing viral detection and quantification market is experiencing a surge in demand for consumables and instruments. With technological improvements and a commitment to upholding high standards, the market is well-positioned for ongoing growth in the area.Market Segmentation:
Segmentation 1: by Offering Type
- Consumables
- Instruments
- Services
Segmentation 2: by Technology
- PCR
- ELISA
- Flow Cytometry
- Plaque Assay
- Others
Segmentation 3: by Application
- Blood and Blood Products Manufacturing
- Vaccines and Therapeutics Manufacturing
- Cellular and Gene Therapy Products Manufacturing
- Stem Cell Products Manufacturing
- Tissue and Tissue Products Manufacturing
Segmentation 4: by End User
- Life Science Companies
- Testing Laboratories
- CROs and CDMOs
Segmentation 6: by Country
- Germany
- France
- U.K.
- Spain
- Italy
- Rest-of-Europe
How can this report add value to an organization?
Workflow/Innovation Strategy: The biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.
Competitive Strategy: Key players in the Europe biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the Europe biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.Some of the prominent names in this market are:
- Merck KGaA
- Sartorius AG
- QIAGEN N.V.
This product will be delivered within 3-5 business days.
Table of Contents
1 Product Definition
2 Market Scope
4 Europe
5 Markets - Competitive Benchmarking & Company Profiles
List of Figures
List of Tables
Executive Summary
The Europe biomanufacturing viral detection and quantification market is estimated to reach $345.9 million by 2032, reveals the premium market intelligence study. The study also highlights that the market is set to witness a CAGR of 9.80% during the forecast period 2023-2032.The Europe Biomanufacturing Viral Detection and Quantification Market: Drivers and Challenges
Market Drivers
- Research initiatives to enhance the accuracy, efficiency, and accessibility of viral testing assays
- Technological advancements in viral detection and quantification
Market Restraints
- Lack of consistent standards and guidelines for viral detection and quantification
USPs of report
Market ranking analysis based on product portfolios and recent developments
- Analysis of business drivers and challenges of the Europe Biomanufacturing Viral Detection and Quantification Market
- Detailed analysis of Biomanufacturing Viral Detection and Quantification Market for Germany, France, Italy, Spain, and U.K.
- Segmentation by offering type, technology, application, and end user provided in the report
Analyst’s Perspective on Biomanufacturing Viral Detection and Quantification Market
The Principal Analyst states, 'The biomanufacturing viral detection and quantification market is experiencing rapid growth due to the increasing utilization of biopharmaceuticals. Robust quality control processes are essential to ensure the safety, efficacy, and consistency of biologics. The market is driven by the need for stringent QC measures throughout the manufacturing journey, advancements in testing technologies, and expanding regulatory frameworks. The biomanufacturing viral detection and quantification market has witnessed a steady growth in the number of new entrants and investments in biopharmaceuticals, thereby driving a surge in demand for the products and services required in the manufacturing and QC of biologics. This trend is also expected to continue over the forecast period. Therefore, the impact of the aforementioned factors is expected to drive the biomanufacturing viral detection and quantification market in the near future.'Some of the prominent names in this market are:
- Merck KGaA
- Sartorius AG
- QIAGEN N.V.
Key Questions Answered in the Report
- What are the key drivers, restraints, and opportunities for Europe biomanufacturing viral detection and quantification market? What will be their impact on the market in the short, mid, and long-term duration?
- Which offering type is projected to be the fastest-growing segment during the forecast period 2023-2032?
- Who are the key players in the Europe biomanufacturing viral detection and quantification market, and what are their product offerings in the market?
Companies Mentioned
- Merck KGaA
- Sartorius AG
- QIAGEN N.V.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 81 |
Published | November 2023 |
Forecast Period | 2023 - 2032 |
Estimated Market Value ( USD | $ 149.2 Million |
Forecasted Market Value ( USD | $ 345.9 Million |
Compound Annual Growth Rate | 9.8% |
Regions Covered | Europe |
No. of Companies Mentioned | 3 |